Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism ERG degraders(ETS transcription factor ERG degraders) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Preclinical | US | 23 Mar 2017 | |
Prostatic Cancer | Preclinical | US | 23 Mar 2017 |